6 Einträge gefunden

1. Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients.

   1. Sehouli, Jalid
   2. Richter, R
   3. Braicu, Elena Ioana
   4. Bühling, Kai J.
   5. Bahra, Marcus
   6. Neuhaus, Peter
   7. Lichtenegger, Werner

   2010 - Forschungsinformationssystem des UKE
2. A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer.

   1. Sehouli, Jalid
   2. Camara, Oumar
   3. Mahner, Sven
   4. Bauknecht, Thomas
   5. Lichtenegger, Werner
   6. Runnebaum, Ingo
   7. Look, Katherine

   2010 - Forschungsinformationssystem des UKE
3. Prognostic Value of Serum and Ascites Levels of Estradiol, FSH, LH and Prolactin in Ovarian Cancer.

   1. Chen, Frank Chih-Kang
   2. Oskay-Ozcelik, Guelten
   3. Bühling, Kai J.
   4. Köpstein, Uta
   5. Mentze, Monika
   6. Lichtenegger, Werner
   7. Sehouli, Jalid

   2009 - Forschungsinformationssystem des UKE
4. Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational study.

   1. Sehouli, Jalid
   2. Camara, O
   3. Schmidt, M
   4. Mahner, Sven
   5. Seipelt, G
   6. Otremba, B
   7. Schmalfeldt, B

   2009 - Forschungsinformationssystem des UKE
5. Prognostic Significance of CA-125 in the Management of Patients with Recurrent Epithelial Ovarian Carcinoma Selected for Secondary Cytoreduction.

   1. Mahner, Sven
   2. Wölber, Linn
   3. Jung, Sabine
   4. Zu Eulenburg, Christine Gräfin
   5. Henningsen, Maike
   6. Schwarz, Joerg
   7. Sehouli, Jalid

   2009 - Forschungsinformationssystem des UKE
6. Independent association between leptin and blood pressure during third trimester in normal and gestational diabetic pregnancies.

   1. Bühling, Kai J.
   2. Harder, Thomas
   3. Sehouli, Jalid
   4. Nanz, Jennifer
   5. Plagemann, Andreas
   6. Dudenhausen, Joachim W

   2005 - Forschungsinformationssystem des UKE